Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,063 public trials 1,834 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

NCT04956692

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • St. Bernards Medical Center ( Site 0103) Jonesboro, Arkansas, United States
  • St Joseph Heritage Healthcare-Oncology ( Site 0102) Fullerton, California, United States
  • Cancer Blood and Specialty Clinic ( Site 0105) Los Alamitos, California, United States
  • PIH Health Hematology Medical Oncology ( Site 0106) Whittier, California, United States
View all 126 locations
View Trial Details
Active, Not Recruiting

A Study of NDI 1150-101 in Patients With Solid Tumors

NCT05128487

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +45 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Emory University Atlanta, Georgia, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • R.J.Zuckerberg Cancer Center Lake Success, New York, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients

NCT04127110

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Institut Jules Bordet-Hopital Universitaire ULB Brussels, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Universitair Ziekenhuis Antwerpen Edegem, Belgium
  • CHU-UCL Namur - CHU Mont Godinne - UCL Namur Yvoir, Belgium
View all 26 locations
View Trial Details

Related conditions